Clinical Research Directory
Browse clinical research sites, groups, and studies.
Towards Personalized Medicine for Refractory/Relapsed Follicular Lymphoma Patients: the Cantera/Lupiae Registry
Sponsor: European Hematology Association - Lymphoma Group
Summary
The optimal treatment strategy in patients with early progressive disease is not well known. In recent years, novel insights into the biology of Follicular Lymphoma (FL), and especially the role of the microenvironment, have resulted in the development of multiple novel treatment modalities. These new agents may ultimately improve the outlook for patients with FL with an unfavorable course, but for the development of the optimal therapeutic strategy, knowledge on the clinical and biological determinants of early refractory FL is needed.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2019-05-22
Completion Date
2026-05-22
Last Updated
2020-10-14
Healthy Volunteers
No
Locations (11)
Klinički Bolnički Centar Split
Split, Croatia
AOU Città della Salute e della Scienza di Torino
Torino, Italy
Academic Medical Center
Amsterdam, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Instituto Português de Oncologia Francisco Gentil
Lisbon, Portugal
Hospital Clinic de Barcelona
Barcelona, Spain
Hospital 12 de Octubre
Madrid, Spain
Hospital Jose Maria Morales Meseguer
Murcia, Spain
Hospital de Son Llàtzer
Palma, Spain
Hospital Universitario de Salamanca
Salamanca, Spain
Kiev National Cancer Institute
Kiev, Ukraine